MedTrace Logo

Evaluate the Safety and Efficacy of Botulax® Versus Botox® in Patient With Overactive Bladder

NCT04186442 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2022-04-15

No results posted yet for this study

Summary

To determine the efficacy and safety of Botulax® in treatment of Overactive Bladder

Conditions

Interventions

DRUG

Botulinum toxin type A injection

Experimental

DRUG

Botulinum Toxin Type A Injection [Botox]

Active Comparator

Sponsors & Collaborators

  • Hugel

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-12
Primary Completion
2021-04-26
Completion
2021-10-26

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04186442 on ClinicalTrials.gov